1-[2-(dimethylamino)-2-oxoethyl]-N-[2-(2,6-dimethylmorpholin-4-yl)-2-methylpropyl]triazole-4-carboxamide
C17H30N6O3 — CID 136578962
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[2-(dimethylamino)-2-oxoethyl]-N-[2-(2,6-dimethylmorpholin-4-yl)-2-methylpropyl]triazole-4-carboxamide
1-[2-(dimethylamino)-2-oxoethyl]-N-[2-(2,6-dimethylmorpholin-4-yl)-2-methylpropyl]triazole-4-carboxamide (PubChem CID 136578962) has the molecular formula C17H30N6O3 and a molecular weight of 366.47 g/mol. Its IUPAC name is 1-[2-(dimethylamino)-2-oxoethyl]-N-[2-(2,6-dimethylmorpholin-4-yl)-2-methylpropyl]triazole-4-carboxamide.
Molecular Properties
| Compound Name | 1-[2-(dimethylamino)-2-oxoethyl]-N-[2-(2,6-dimethylmorpholin-4-yl)-2-methylpropyl]triazole-4-carboxamide |
|---|---|
| PubChem CID | 136578962 |
| Molecular Formula | C17H30N6O3 |
| Molecular Weight | 366.47 g/mol |
| Exact Mass | 366.24 |
| IUPAC Name | 1-[2-(dimethylamino)-2-oxoethyl]-N-[2-(2,6-dimethylmorpholin-4-yl)-2-methylpropyl]triazole-4-carboxamide |
| SMILES | CC1CN(C(C)(C)CNC(=O)c2cn(CC(=O)N(C)C)nn2)CC(C)O1 |
| InChI | InChI=1S/C17H30N6O3/c1-12-7-22(8-13(2)26-12)17(3,4)11-18-16(25)14-9-23(20-19-14)10-15(24)21(5)6/h9,12-13H,7-8,10-11H2,1-6H3,(H,18,25) |
| InChIKey | AXOXMQNKSVQVIS-UHFFFAOYSA-N |
| XLogP | -0.02 |
| TPSA | 92.59 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 366.47 |
| LogP ≤ 5 | -0.02 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 136578962 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.